Oberweis Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-506,600
Closed -$18.2M 213
2024
Q4
$18.2M Buy
506,600
+58,550
+13% +$1.98M 0.86% 35
2024
Q3
$19M Buy
448,050
+166,050
+59% +$7.04M 0.97% 25
2024
Q2
$11.4M Buy
+282,000
New +$11.8M 0.7% 51
2021
Q1
Sell
-36,980
Closed -$3.54M 181
2020
Q4
$3.54M Sell
36,980
-16,390
-31% -$1.69M 0.93% 16
2020
Q3
$6.06M Sell
53,370
-5,855
-10% -$615K 2.04% 8
2020
Q2
$5.86M Sell
59,225
-8,405
-12% -$671K 2.3% 9
2020
Q1
$4.35M Sell
67,630
-42,310
-38% -$2.96M 2.4% 6
2019
Q4
$6.55M Sell
109,940
-89,470
-45% -$5.52M 2.18% 6
2019
Q3
$11.8M Sell
199,410
-16,510
-8% -$1.05M 2.66% 5
2019
Q2
$13.9M Buy
215,920
+24,800
+13% +$1.6M 2.53% 5
2019
Q1
$12.1M Sell
191,120
-33,740
-15% -$1.77M 2.44% 6
2018
Q4
$8.54M Sell
224,860
-190
-0.1% -$6.71K 1.91% 7
2018
Q3
$9.64M Buy
+225,050
New +$7.86M 1.87% 9

Other funds holding TNDM

Oberweis Asset Management's TNDM Position: Q1 2025 in Review

Oberweis Asset Management sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 506,600 shares — an estimated $18.2M sold.

Oberweis Asset Management first reported a position in TNDM in Q3 2018 and held it in 13 quarters. The position peaked at $19M in Q3 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Oberweis Asset Management reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Oberweis Asset Management sold 506,600 Tandem Diabetes Care shares in Q1 2025, an estimated $18.2M.
  • Oberweis Asset Management first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 13 quarters.
  • Oberweis Asset Management's Tandem Diabetes Care position peaked at $19M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Oberweis Asset Management's 13F filing for Q1 2025, filed 15 May 2025.